Equities

WELL Health Technologies Corp

WELL Health Technologies Corp

Actions
  • Price (EUR)3.43
  • Today's Change0.23 / 7.19%
  • Shares traded100.00
  • 1 Year change+19.93%
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024 08:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.

  • Revenue in CAD (TTM)957.69m
  • Net income in CAD73.43m
  • Incorporated2010
  • Employees2.20k
  • Location
    WELL Health Technologies CorpSuite 550 - 375 Water StreetVANCOUVER V6B 5C6CanadaCAN
  • Phone+1 (604) 628-7266
  • Fax+1 (604) 628-7266
  • Websitehttps://www.well.company/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
WELL:TOR since
announced
Transaction
value
Manitoba Clinic Holding Co LtdDeal completed01 Dec 202301 Dec 2023Deal completed30.79%--
Data delayed at least 15 minutes, as of Nov 11 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.